Wikidata

(Q42996491)

English

A phase I trial of an antisense inhibitor of hepatitis C virus (ISIS 14803), administered to chronic hepatitis C patients

scientific article published on 25 October 2005

In more languages

Statements

title
A phase I trial of an antisense inhibitor of hepatitis C virus (ISIS 14803), administered to chronic hepatitis C patients (English)
1 reference
stated in
Europe PubMed Central
PubMed ID
16274834
retrieved
12 November 2017
author name string
John G McHutchison
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed ID
16274834
retrieved
12 November 2017
Keyur Patel
series ordinal
2
1 reference
stated in
Europe PubMed Central
PubMed ID
16274834
retrieved
12 November 2017
Paul Pockros
series ordinal
3
1 reference
stated in
Europe PubMed Central
PubMed ID
16274834
retrieved
12 November 2017
Lisa Nyberg
series ordinal
4
1 reference
stated in
Europe PubMed Central
PubMed ID
16274834
retrieved
12 November 2017
Stephen Pianko
series ordinal
5
1 reference
stated in
Europe PubMed Central
PubMed ID
16274834
retrieved
12 November 2017
Rosie Z Yu
series ordinal
6
1 reference
stated in
Europe PubMed Central
PubMed ID
16274834
retrieved
12 November 2017
F Andrew Dorr
series ordinal
7
1 reference
stated in
Europe PubMed Central
PubMed ID
16274834
retrieved
12 November 2017
T Jesse Kwoh
series ordinal
8
1 reference
stated in
Europe PubMed Central
PubMed ID
16274834
retrieved
12 November 2017
publication date
25 October 2005
1 reference
stated in
Europe PubMed Central
PubMed ID
16274834
retrieved
12 November 2017
page(s)
88-96
1 reference
stated in
Europe PubMed Central
PubMed ID
16274834
retrieved
12 November 2017

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q42996491&oldid=1976294414"